Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dual Nature of Electromagnetic (EM) Radiation01:10

Dual Nature of Electromagnetic (EM) Radiation

3.8K
Electromagnetic (EM) radiation consists of electric and magnetic field components oscillating in planes perpendicular to each other and mutually perpendicular to radiation propagation through space. EM radiation can be classified as a wave, characterized by the properties of waves such as wavelength (denoted as λ) and frequency (represented by ν).
Wavelength is the distance between two consecutive peaks (the highest point) or troughs (the lowest point) in the wave. Frequency is the number of...
3.8K
What is Evolutionary History?02:35

What is Evolutionary History?

43.2K
Scientists record evolutionary history by analyzing fossil, morphological, and genetic data. The fossil record documents the history of life on Earth and provides evidence for evolution. However, both fossil and living organisms offer evidence that outlines Earth’s evolutionary history.
43.2K
Cancer Therapies02:49

Cancer Therapies

10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Biological Effects of Radiation02:59

Biological Effects of Radiation

17.8K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
17.8K
History of Microbiology01:28

History of Microbiology

9.0K
Microbiology, a scientific field dedicated to the study of microorganisms, has undergone profound development since its inception in the 17th century. Its history is marked by key discoveries and technological advancements that have shaped our understanding of life at the microscopic level and transformed medicine, agriculture, and industry.Early Foundations of MicrobiologyThe early foundations of microbiology were built on groundbreaking observations and the development of pioneering...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities.

Seminars in radiation oncology·2026
Same author

Phenotyping Prostate Cancer in a National Health System Using Large Language Models.

JCO clinical cancer informatics·2026
Same author

Serious Illness and Health Care Threats to Personal Legacy Goals.

The Permanente journal·2026
Same author

Trial protocol: RadTARGET, a multicenter phase II randomized controlled trial evaluating focal radiotherapy boost with de-intensification of dose to non-suspicious prostate in patients with intermediate- or high-risk prostate cancer.

Clinical and translational radiation oncology·2026
Same author

Germline polygenic score for prostate cancer aggressiveness.

medRxiv : the preprint server for health sciences·2026
Same author

Disparities in Timeliness of Cancer Diagnosis Across a Multi-Site Academic Health System.

Research square·2026
Same journal

Impact of Radionecrosis and Local Recurrence on Overall Survival After Stereotactic Radiosurgery for Brain Metastases.

Advances in radiation oncology·2026
Same journal

Disease-Site Specific Peer Review Implementation: From Chart Rounds to the Treatment Couch.

Advances in radiation oncology·2026
Same journal

A Preliminary Efficiency Evaluation of Upper Abdominal Breath-Hold Radiation Therapy Following Personalized Screening Using Active Breathing Coordinator.

Advances in radiation oncology·2026
Same journal

Development and Clinical Validation of a Protocol-Agnostic Machine Learning Platform for Automated Treatment Planning in External Beam Radiation Therapy.

Advances in radiation oncology·2026
Same journal

Early Salivary Gland Shrinkage Is Associated With an Increased Risk of Acute Xerostomia in Head and Neck Cancer Radiation Therapy.

Advances in radiation oncology·2026
Same journal

Encouraging Local Control With Pediatric Spatially Fractionated Radiation Therapy.

Advances in radiation oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

735

Natural History and Risk Stratification of Biochemically Recurrent Prostate Cancer Following Definitive Radiation

Paul Riviere1,2,3,4, Kylie M Morgan2,3,4, Tyler Nelson3

  • 1Department of Radiation Oncology, University of Washington Fred Hutch Cancer Center, Seattle, WA.

Advances in Radiation Oncology
|January 26, 2026
PubMed
Summary
This summary is machine-generated.

A new risk stratification tool helps identify prostate cancer patients at high risk for metastasis or death after radiation therapy. This validated method uses simple clinical data to guide treatment decisions and clinical trial eligibility.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K
At-Risk Butterfly Captive Propagation Programs to Enhance Life History Knowledge and Effective Ex Situ Conservation Techniques
07:10

At-Risk Butterfly Captive Propagation Programs to Enhance Life History Knowledge and Effective Ex Situ Conservation Techniques

Published on: February 11, 2020

7.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

735
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K
At-Risk Butterfly Captive Propagation Programs to Enhance Life History Knowledge and Effective Ex Situ Conservation Techniques
07:10

At-Risk Butterfly Captive Propagation Programs to Enhance Life History Knowledge and Effective Ex Situ Conservation Techniques

Published on: February 11, 2020

7.6K

Area of Science:

  • Oncology
  • Urology
  • Clinical Medicine

Background:

  • Biochemical recurrence (BCR) of prostate cancer post-radiation therapy lacks validated risk stratification methods.
  • Identifying patients at high risk for metastasis or death is crucial for effective management.

Purpose of the Study:

  • To characterize the natural history of BCR after radiation therapy.
  • To validate the proposed European consensus guidelines for risk stratification in postradiation BCR patients.

Main Methods:

  • Retrospective, multicenter, nationwide cohort study of US Veterans Affairs patients with postradiation BCR.
  • High-risk BCR defined by Gleason score ≥8 or BCR within 18 months of radiation therapy.

Main Results:

  • Among 7126 patients, 35.5% developed metastases and 17.4% died of prostate cancer within 10 years.
  • High-risk BCR (38.5% of patients) was associated with significantly higher rates of metastatic disease (56.2% vs 42.0%) and prostate cancer mortality (aHR=1.82).
  • High-risk BCR also correlated with increased all-cause mortality (aHR=1.18).

Conclusions:

  • A simple, 2-element risk stratification tool using existing clinical data is the first validated method for identifying high-risk patients postradiation BCR.
  • This tool is essential for guiding treatment decisions and refining patient populations for clinical trials.
  • Most patients with BCR do not develop metastatic or lethal prostate cancer, underscoring the need for accurate stratification.